StockData
Biotricity Inc. logo

Biotricity Inc. (BTCY) stock

BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$0.05+0.00 (+8.70%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Biotricity operating margin

Operating margin is operating income as a percentage of revenue.

Biotricity's operating margin for the twelve months ending Jun 30, 2026 was 9.6%. For fiscal 2026 it was 10.6%, against -17.8% the year before. The highest annual figure on record is 10.6% in fiscal 2026.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 202610.6%+28.3
FY2025Mar 31, 2025-17.8%+55.4
FY2024Mar 31, 2024-73.2%+86.7
FY2023Mar 31, 2023-159.9%+58.9
FY2022Mar 31, 2022-218.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jun 30, 20263.7%−3.6
Q4 FY2026CQ1 2026Mar 31, 202616.3%+39.4
Q3 FY2026CQ4 2025Dec 31, 202511.1%+15.7
Q2 FY2026CQ3 2025Sep 30, 20257.0%+16.5
Q1 FY2026CQ2 2025Jun 30, 20257.3%+42.2
Q4 FY2025CQ1 2025Mar 31, 2025-23.1%+72.7
Q3 FY2025CQ4 2024Dec 31, 2024-4.7%+38.4
Q2 FY2025CQ3 2024Sep 30, 2024-9.4%+66.2
Q1 FY2025CQ2 2024Jun 30, 2024-34.9%+41.8
Q4 FY2024CQ1 2024Mar 31, 2024-95.8%+30.1
Q3 FY2024CQ4 2023Dec 31, 2023-43.1%+113.0
Q2 FY2024CQ3 2023Sep 30, 2023-75.6%+102.7
Q1 FY2024CQ2 2023Jun 30, 2023-76.7%+168.7
Q4 FY2023CQ1 2023Mar 31, 2023-125.9%–
Q3 FY2023CQ4 2022Dec 31, 2022-156.1%–
Q4 FY2022CQ1 2022Mar 31, 2022-178.3%–
Q3 FY2022CQ4 2021Dec 31, 2021-245.3%–

More Biotricity figures

See a number that looks wrong?